FDA Approved: SUNOSI — Supplemental Application (Axsome Therapeutics, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Sunosi (solriamfetol) from Axsome Therapeutics, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy
• Obstructive Sleep Apnea

Drugs mentioned

• Sunosi (solriamfetol)

Snippet

SUPPL AP for SUNOSI (SOLRIAMFETOL)